Trademark: 88175258
Word
DAXNEU
Status
Pending
Status Code
730
Status Date
Monday, November 25, 2019
Serial Number
88175258
Mark Type
4000
Filing Date
Tuesday, October 30, 2018
Published for Opposition
Tuesday, April 2, 2019

Trademark Owner History
Revance Therapeutics, Inc - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; body creams, lotions and gels for medical purposes; eye creams, lotions and gels for medical purposes

Trademark Events
Nov 27, 2019
Notice Of Approval Of Extension Request E-Mailed
Nov 25, 2019
Extension 1 Granted
Nov 25, 2019
Extension 1 Filed
Nov 25, 2019
Teas Extension Received
May 28, 2019
Noa E-Mailed - Sou Required From Applicant
Apr 2, 2019
Official Gazette Publication Confirmation E-Mailed
Apr 2, 2019
Published For Opposition
Mar 13, 2019
Notification Of Notice Of Publication E-Mailed
Feb 25, 2019
Assigned To Lie
Feb 7, 2019
Approved For Pub - Principal Register
Feb 7, 2019
Examiner's Amendment Entered
Feb 7, 2019
Notification Of Examiners Amendment E-Mailed
Feb 7, 2019
Examiners Amendment E-Mailed
Feb 7, 2019
Examiners Amendment -Written
Feb 5, 2019
Assigned To Examiner
Nov 15, 2018
New Application Office Supplied Data Entered In Tram
Nov 2, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2020-02-21